Analytical Data
-
基因名
EphB2
-
简介
The EphB2 protein is a receptor tyrosine kinase that binds to the transmembrane ephrin B ligand on adjacent cells to initiate bidirectional signaling. The forward signal originates from the receptor, while the reverse signal originates from the ephrin ligand. EphB2 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived EphB2 protein, expressed by HEK293 , with C-His labeled tag.
- Application
-
别名
DRT; ERK; HEK5; TYRO5; CAPB; EK5; EPHT3; PCBC; Cek5; EphB2; EPHT3MGC87492; Nuk; Qek2; Sek3
-
种属
Cynomolgus
-
表达系统
HEK293
-
标签
C-8*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A0A7N9CQH5
-
表达区间
V19-P542
-
蛋白长度
Partial
-
分子量
65-75 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EphB2 is a member of the Eph receptor tyrosine kinase family, which plays a critical role in various biological processes, including cell adhesion, migration, and axon guidance. The EphB2 protein has garnered significant interest due to its involvement in neurodevelopment and potential implications in cancer biology, particularly its association with tumor progression and metastasis. Aberrant expression of EphB2 has been linked to various malignancies, making it a target for cancer therapeutics. Research has shown that EphB2 can modulate tumor microenvironments and influence the behavior of both tumor cells and neighboring stromal cells. In this context, the recombinant expression of EphB2 provides a valuable tool for biochemical and biophysical studies, enabling the exploration of its structure-function relationships and interactions with ligands such as ephrin-Bs. Furthermore, the generation of EphB2 recombinant proteins facilitates the development of assays for high-throughput screening of small molecules or antibodies that could inhibit or enhance its activity. This line of research holds promise for uncovering novel therapeutic strategies for diseases associated with EphB2 dysregulation, ultimately contributing to improved outcomes for patients facing aggressive cancers.
